Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Ranibizumab(Lucentis®))
Ranibizumab(Lucentis®))
NICE TA 155, TA 274, TA 283 and TA 298
- Traffic Light
Red
- BNF
11.8.2
- Licensed Indicators
Choroidal neovascularisation, Macular oedema, Macular degeneration
- Reference
APC Dec 13
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik